Dr Reddy’s Laboratories on Tuesday said its subsidiary Promius Pharma sold rights of specialty skin cream Cloderm and its authorised generic to EPI Health. "Under the terms of the agreement, Promius ...

HYDERABAD, India, and MISSISSAUGA, Ontario, April 1, 2011 /PRNewswire/ -- Promius Pharma, LLC, an affiliate of Dr. Reddy's Laboratories (NYSE:RDY), and Valeant Pharmaceuticals International, Inc.

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Promius Pharma an affiliate of Dr Reddy's Laboratories and Valeant Pharmaceuticals International Inc. jointly announced that they has signed a collaboration agreement for Cloderm (clocortolone ...

Promius Pharma LLC, an arm of Dr Reddy's Laboratories, today said it has bought the USA marketing rights of Cloderm (clocortolone pivalate 0.1%) cream manufactured by Canada-based Valeant ...

https://www.thehindubusinessline.com/companies/dr-reddys-sells-cloderm-cream-franchise-to-epi-health/article25103232.ece Copy Dr Reddy’s Laboratories Ltd, the ...

HYDERABAD, India, and MISSISSAUGA, Ontario, April 1, 2011 /PRNewswire/ -- Promius Pharma, LLC, an affiliate of Dr. Reddy's Laboratories , and Valeant Pharmaceuticals International, Inc. today jointly ...

New Delhi, Oct 2 (PTI) Dr Reddy’s Laboratories (DRL) Tuesday said its wholly-owned subsidiary Promius Pharma has sold rights of cloderm cream and its authorised generic to EPI Health, LLC. “Promius ...

"Promius Pharma, LLC, has sold its rights of Cloderm (clocortolone pivalate) cream, 0.1 per cent and its authorised generic to EPI Health, LLC, an affiliate of EPI Group, LLC," DRL said in a statement ...

Dr. Reddy’s Laboratories’ wholly owned U.S. subsidiary Promius Pharma has sold rights of Cloderm (clocortolone pivalate) cream and its authorised generic to EPI Health. Under the agreement, Promius ...